Hungarian parliament rules out Orbán return with eight-year limit for prime ministers
Hungary's parliament on Monday approved a constitutional amendment limiting prime ministers to a maximum of eight years in office, a move that effecti...
Indian police have arrested the owner of Sresan Pharmaceutical Manufacturer, the cough syrup company linked to the deaths of at least 19 children in the central state of Madhya Pradesh, a senior police officer told Reuters on Thursday.
The children, all under five years of age, died in the past month in the state's Chhindwara city, after consuming cough medicine containing toxic diethylene glycol in quantities nearly 500 times the permissible limit.
The deaths were all linked to Sresan Pharma's Coldrif syrup, which has been banned in several parts of India after a test confirmed the presence of the chemical last Thursday.
SYRUP FACTORY OWNER ARRESTED
S.Ranganathan, owner of the Tamil Nadu state-based company that manufactured the syrup, was arrested on Wednesday in Chennai where he will appear in court before being moved to Chhindwara, the Chhindwara Superintendent of Police Ajay Pandey told Reuters.
Local drug authorities have stepped up efforts to curb the circulation of contaminated medicine, testing random samples of cough syrups and making door-to-door calls to retrieve Coldrif bottles,
"We (have) got 30-40 bottles (through this means)...we (also) recalled some from retailers and stockists," district administrator Harendra Narayan said, adding that 594 bottles of the syrup were sold to pharmaceutical stockists in the region over the last six weeks.
By law, Indian drugmakers must test each batch of raw materials and the final product.
Exports of cough syrup require another layer of tests at government-mandated laboratories since 2023, after the deaths of over 10 children in Gambia, Uzbekistan and Cameroon were linked to Indian syrups.
The World Health Organization has said the recent case highlights a "regulatory gap" in India’s screening of medicines being sold domestically, and warned that some exports could have been made unofficially.
Indian authorities have asked people to avoid two other locally-sold syrups, Respifresh and RELIFE, made by Gujarat state-based Shape Pharma and Rednex Pharmaceuticals, after tests found they contained the same toxic chemical
Known as the "pharmacy of the world", India is the third-largest drug producer by volume after the U.S. and China.
The country supplies 40% of generic medicines used in the U.S., and more than 90% of all medicines in many African nations.
Details of a reported draft memorandum of understanding between the United States and Iran offer the clearest picture yet of how both sides plan to end months of conflict and move towards a longer-term settlement.
The U.S. and Iran say they have reached a deal to end their conflict, with an immediate ceasefire and reopening of the Strait of Hormuz after the lifting of the U.S. naval blockade. Talks will continue over the next 60 days to finalise the agreement
A senior U.S. official said on Monday that the memorandum of understanding linked to the U.S.-Iran agreement had been signed by President Donald Trump, Vice President JD Vance and Iranian Parliament Speaker Mohammad Bagher Qalibaf.
Israeli Prime Minister Benjamin Netanyahu has told U.S. President Donald Trump that Israel does not consider itself bound by a Lebanon-related provision in an emerging agreement with Iran, according to Israeli officials.
Switzerland on Sunday rejected a referendum proposal to cap its population at 10 million, a projection showed, as voters prioritised economic stability and the country's ties with the European Union over immigration concerns.
A U.S. doctor who contracted Ebola while on a humanitarian mission in the Democratic Republic of Congo has recovered and been discharged from a hospital in Germany, according to officials.
Protesters in Nanyuki blocked roads and burned tyres after residents challenged a U.S. plan to house Americans exposed to Ebola at a nearby military base.
Global health organisation CEPI will provide around $60 million to Moderna and two other partners to speed up the development of vaccines targeting the Ebola Bundibugyo strain, which is currently driving an outbreak in eastern Democratic Republic of Congo.
The head of the World Health Organization (WHO) has warned that the Ebola outbreak in the Democratic Republic of Congo may be significantly larger than official figures suggest, following a visit to the country where he briefed President Felix Tshisekedi on the ongoing response.
Four nurses have recovered and been discharged after receiving treatment for Ebola in the Democratic Republic of Congo, the World Health Organisation (WHO) said.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment